3
3Scan
Biotech & Life Sciences · San Francisco, United States · Founded 2011
Offers automated microscopy services and supporting software for the 3D analysis of cells, tissues, and organs MoreLess
3Scan, now part of Strateos, operates in the biotechnology sector, providing advanced robotic cloud lab services that accelerate biological research and development. The company specializes in automated tissue imaging and experimentation, serving clients such as pharmaceutical companies, research institutions, and biotech firms. By leveraging robotic systems and cloud-based platforms, 3Scan enables high-throughput and precise biological experiments, significantly reducing the time and cost associated with traditional laboratory work. Their business model revolves around offering subscription-based access to their cloud lab services, as well as custom project-based solutions. Revenue is generated through service fees, collaborations, and grants. The company has established notable partnerships with industry leaders like Ginkgo Bioworks and Eli Lilly, further solidifying its position in the market.
Keywords: robotic cloud lab, tissue imaging, biological research, automation, biotechnology, pharmaceutical, research institutions, high-throughput, cloud-based, partnerships.
Talent graph
3Scan's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where 3Scan has talent and traffic
team presence
Market sentiment
What the market is saying about 3Scan
An AI-synthesized read of the highest-engagement posts about 3Scan on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See 3Scan on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.









